Guangwei Xu

Tianjin Key Laboratory Of Basic And Translational Medicine On Head & Neck Cancer
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A nomogram as a predictive tool for lymph node metastasis in papillary thyroid carcinoma.

A nomogram as a predictive tool for lymph node metastasis in papillary thyroid carcinoma.

Journal: Frontiers in endocrinology

Published: April 08, 2026

Prognostic value and therapeutic potential of the cuproptosis-related gene LOXL2 in thyroid cancer.

Prognostic value and therapeutic potential of the cuproptosis-related gene LOXL2 in thyroid cancer.

Journal: Translational oncology

Published: March 09, 2026

Identification of stemness subtypes and prognostic modeling in thyroid cancer: the critical role of DPYSL3 in tumor progression and immune microenvironment.

Identification of stemness subtypes and prognostic modeling in thyroid cancer: the critical role of DPYSL3 in tumor progression and immune microenvironment.

Journal: Discover oncology

Published: March 05, 2025

The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma.

The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma.

Journal: Cell death & disease

Published: October 30, 2024

Persistent pre-exhausted CD8+ T cells shape the tumor immune microenvironment in anaplastic thyroid cancer.

Persistent pre-exhausted CD8+ T cells shape the tumor immune microenvironment in anaplastic thyroid cancer.

Journal: Endocrine-related cancer

Published: July 14, 2024

SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling.

SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 17, 2024

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib.

Journal: Cell death & disease

Published: June 30, 2021

Genome-wide identification of m6A-associated functional SNPs as potential functional variants for thyroid cancer.

Genome-wide identification of m6A-associated functional SNPs as potential functional variants for thyroid cancer.

Journal: American journal of cancer research

Published: June 01, 2021

Ultrasound features of medullary thyroid cancer as predictors of biological behavior.

Ultrasound features of medullary thyroid cancer as predictors of biological behavior.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: April 02, 2020

Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway.

Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway.

Journal: PLoS biology

Published: February 08, 2020

A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma.

A highly potent and selective inhibitor Roxyl-WL targeting IDO1 promotes immune response against melanoma.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: June 23, 2018

Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate.

Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate.

Journal: Bioorganic & medicinal chemistry letters

Published: March 07, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026